MedTrace Logo

The Impact of Interscalene Block on Sleep Disordered Breathing

NCT03718858 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2024-08-14

No results posted yet for this study

Summary

This is a randomized controlled trial evaluating the impact of interscalene block on worsening of upper airway collapse in sleep disordered breathing for patients undergoing ambulatory shoulder surgery.

Conditions

Interventions

PROCEDURE

Interscalene Block

15 mL ropivacaine 0.5% will be injected in 5 mL aliquots in order to achieve spread adjacent to C5 and C6 nerve roots.

PROCEDURE

Superior Trunk Nerve Block

15 mL ropivacaine 0.5% will be injected in 5 mL aliquots in order to achieve spread adjacent to Superior Trunk Nerve.

Sponsors & Collaborators

  • University Health Network, Toronto

    collaborator OTHER

  • Women's College Hospital

    lead OTHER

Principal Investigators

  • Dr. Mandeep Singh · Women's College Hospital and Toronto Western Hospital, University Health Network

  • Dr. Richard Brull · Women's College Hospital and Toronto Western Hospital, University Health Network

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-23
Primary Completion
2024-06-21
Completion
2024-07-04

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03718858 on ClinicalTrials.gov